Drew Moghanaki: Why Lung Cancer Survival Rates Are Higher in the VA System
Drew Moghanaki/LinkedIn

Drew Moghanaki: Why Lung Cancer Survival Rates Are Higher in the VA System

Drew Moghanaki, Nancy Stark Endowed Chair in Thoracic Radiation Oncology Research at David Geffen School of Medicine at UCLA, shared on LinkedIn:

“Why are lung cancer survival rates better in the VA than in the broader U.S. healthcare system? Our editorial explores the potential reasons.”

 

Title: Reconsidering community care referrals for Veterans with lung cancer

Authors: Drew Moghanaki, David Harpole, Michael Kelley

Read the full article.

HER2 Mutations in NSCLC: Critical Risks of Outdated Terms

Drew Moghanaki: Why Lung Cancer Survival Rates Are Higher in the VA System